ASMB
Price
$25.20
Change
-$0.56 (-2.17%)
Updated
Aug 19, 04:59 PM (EDT)
Capitalization
193.49M
VKTX
Price
$24.34
Change
-$17.75 (-42.17%)
Updated
Aug 19, 04:59 PM (EDT)
Capitalization
2.74B
63 days until earnings call
Interact to see
Advertisement

ASMB vs VKTX

Header iconASMB vs VKTX Comparison
Open Charts ASMB vs VKTXBanner chart's image
Assembly Biosciences
Price$25.20
Change-$0.56 (-2.17%)
Volume$1.25K
Capitalization193.49M
Viking Therapeutics
Price$24.34
Change-$17.75 (-42.17%)
Volume$205.76K
Capitalization2.74B
ASMB vs VKTX Comparison Chart in %
Loading...
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASMB vs. VKTX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a Buy and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 20, 2025
Stock price -- (ASMB: $25.76 vs. VKTX: $42.09)
Brand notoriety: ASMB and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASMB: 159% vs. VKTX: 121%
Market capitalization -- ASMB: $193.49M vs. VKTX: $2.74B
ASMB [@Biotechnology] is valued at $193.49M. VKTX’s [@Biotechnology] market capitalization is $2.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.19B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASMB’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • ASMB’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than ASMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASMB’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • ASMB’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ASMB and VKTX are a good buy in the short-term.

Price Growth

ASMB (@Biotechnology) experienced а +9.15% price change this week, while VKTX (@Biotechnology) price change was +10.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.77%. For the same industry, the average monthly price growth was +18.45%, and the average quarterly price growth was +20.12%.

Reported Earning Dates

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+2.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.74B) has a higher market cap than ASMB($193M). ASMB YTD gains are higher at: 63.245 vs. VKTX (4.597). ASMB has higher annual earnings (EBITDA): -43.39M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. ASMB (75M). VKTX has less debt than ASMB: VKTX (878K) vs ASMB (2.88M). ASMB has higher revenues than VKTX: ASMB (33.2M) vs VKTX (0).
ASMBVKTXASMB / VKTX
Capitalization193M2.74B7%
EBITDA-43.39M-212.42M20%
Gain YTD63.2454.5971,376%
P/E RatioN/AN/A-
Revenue33.2M0-
Total Cash75M808M9%
Total Debt2.88M878K328%
FUNDAMENTALS RATINGS
ASMB vs VKTX: Fundamental Ratings
ASMB
VKTX
OUTLOOK RATING
1..100
2823
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
10065
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
3540
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (48) in the Biotechnology industry is in the same range as ASMB (63) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to ASMB’s over the last 12 months.

VKTX's Profit vs Risk Rating (65) in the Biotechnology industry is somewhat better than the same rating for ASMB (100) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew somewhat faster than ASMB’s over the last 12 months.

VKTX's SMR Rating (95) in the Biotechnology industry is in the same range as ASMB (99) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to ASMB’s over the last 12 months.

ASMB's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as VKTX (40) in the Biotechnology industry. This means that ASMB’s stock grew similarly to VKTX’s over the last 12 months.

ASMB's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as VKTX (100) in the Biotechnology industry. This means that ASMB’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASMBVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RENI0.130.02
+15.61%
Resilient Energy Inc.
ACCMF10.88N/A
N/A
AAC CLYDE SPACE AB
ACNFF25.08N/A
N/A
Amsterdam Commodities N.V.
KBSTF11.82N/A
N/A
Kobe Steel, Ltd.
TRUMF18.94-1.24
-6.16%
Terumo Corp.

ASMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with SPRC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASMB
1D Price
Change %
ASMB100%
+1.26%
SPRC - ASMB
45%
Loosely correlated
+0.67%
ABCZF - ASMB
44%
Loosely correlated
N/A
NKTX - ASMB
42%
Loosely correlated
+0.86%
RGNX - ASMB
34%
Loosely correlated
-1.25%
VKTX - ASMB
33%
Loosely correlated
+5.15%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with CRNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+5.15%
CRNX - VKTX
47%
Loosely correlated
+0.17%
SYRE - VKTX
45%
Loosely correlated
-0.06%
GPCR - VKTX
45%
Loosely correlated
-0.80%
ROIV - VKTX
44%
Loosely correlated
-0.34%
OCUL - VKTX
44%
Loosely correlated
-2.46%
More